About

Publications While At HealthPartners

selected publications

Journal Article

Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials. 

Lancet Oncology. 2018

Abstract

CT066 / 16 - Phase 1 study of MDM2 antagonist ASTX295 in patients with solid tumors with wild-type TP53 [abstract]

2024

Contact

full name

M. M. Milhem

Quick Info

 

Collaboration

Co-author network

Map of science